Phylogenetic analysis and prokaryotic expression of NMAAP1 derived from BCG-activated murine macrophages

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 34, Issue 2, 2011, Pages 123-128

  Zhao, Xiangfeng ^a   Zhang, Linbing ^a   Yan, Dongmei ^a   Feng, Xiuping ^a   Chu, Dun ^a   Li, Bin ^a   Du, Bairong ^a   Zhu, Xun ^a  

^a Basic Medical College   (China)

Author keywords

BCG activated macrophages; NMAAP1; Prokaryotic expression; Sequence and phylogenetic analysis

Indexed keywords

BCG VACCINE; COMPLEMENTARY DNA; HYBRID PROTEIN; MEMBRANE PROTEIN; NOVEL MACROPHAGE ACTIVATED ASSOCIATED PROTEIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; ESCHERICHIA COLI; FEMALE; MACROPHAGE ACTIVATION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROTEIN EXPRESSION; PROTEIN TARGETING; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; BASE SEQUENCE; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VECTORS; MACROPHAGE ACTIVATION; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; PHYLOGENY; RABBITS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, NUCLEIC ACID;

ESCHERICHIA COLI; MURINAE; PROKARYOTA;

EID: 79951768347     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2010.04.002     Document Type: Article

References (35)

1. Cleveland R.P., Meltzer M.S., Zbar B. Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG. J Natl Cancer Inst 1974, 52:1887-1895.
2. Zwilling B.S., Campolito L.B. Destruction of tumor cells by BCG-activated alqolar macrophages. J Immunol 1977, 119:838-841.
3. Adams D.O., Koren H.S. BCG-activated macrophages: comparison as effectors in direct tumor-cell cytotoxicity and antibody dependent cell-mediated cytotoxicity. Adv Exp Med Biol 1979, 121B:195-201.
4. Viadro M.M. Cytotoxic effect of BCG-activated macrophages on tumor target cells in vitro. Biull Eksp Biol Med 1979, 87:36-39.
5. Bai G., Schaak D.D., McDonough K.A. cAMP levels within Mycobacterium tuberculosis and Mycobacterium bovis BCG increase upon infection of macrophages. FEMS Immunol Med Microbiol 2009, 55:68-73.
6. DiStefano J.F., Beck G., Zucker S. Mechanism of BCG-activated macrophage-induced tumor cell cytotoxicity: evidence for both oxygen-dependent and independent mechanisms. Int Arch Allergy Appl Immunol 1983, 70:252-260.
7. Luo Y., Yamada H., Evanoff D.P., Chen X. Role of Th1-stimulating cytokines in bacillus Calmette-Guerin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells. Clin Exp Immunol 2006, 146:181-188.
8. Meltzer M.S., Stevenson M.M. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG. J Immunol 1977, 118:2176-2181.
9. Giri P.K., Schorey J.S. Exosomes derived from M. bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo. PLoS One 2008, 3:e2461.
10. Nascimento F.R., Ribeiro-Dias F., Russo M. Cytotoxic activity of BCG-activated macrophages against L929 tumor cells is nitric oxide-dependent. Braz J Med Biol Res 1998, 31:1593-1596.
11. Wang J., Wakeham J., Harkness R., Xing Z. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest 1999, 103:1023-1029.
12. Atkinson S., Valadas E., Smith S.M., Lukey P.T., Dockrell H.M. Monocyte-derived macrophage cytokine responses induced by M. bovis BCG. Tuber Lung Dis 2000, 80:197-207.
13. Calorini L., Bianchini F., Mannini A., Mugnai G., Balzi M., Becciolini A., et al. IFNgamma and TNFalpha account for a pro-clonogenic activity secreted by activated murine peritoneal macrophages. Clin Exp Metastasis 2002, 19:259-264.
14. Zhang L., Zhu H., Lun Y., Yan D., Yu L., Du B., et al. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing. Cell Mol Immunol 2007, 4:359-367.
15. Tsung K., Dolan J.P., Tsung Y.L., Norton J.A. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Res 2002, 62:5069-5075.
16. Fadok V.A., de Cathelineau A., Daleke D.L., Henson P.M., Bratton D.L. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J Biol Chem 2001, 276:1071-1077.
17. van Rossum D.B., Patterson R.L., Cheung K.H., Barrow R.K., Syrovatkina V., Gessell G.S., et al. DANGER, a novel regulatory protein of inositol 1,4,5-trisphosphate-receptor activity. J Biol Chem 2006, 281:37111-37116.
18. Raghu P., Hasan G. The inositol 1,4,5-triphosphate receptor expression in Drosophila suggests a role for IP3 signalling in muscle development and adult chemosensory functions. Dev Biol 1995, 171:564-577.
19. Ullah G., Jung P., Machaca K. Modeling Ca2+ signaling differentiation during oocyte maturation. Cell Calcium 2007, 42:556-564.
20. Vanderheyden V., Devogelaere B., Missiaen L., De Smedt H., Bultynck G., Parys J.B. Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation. Biochim Biophys Acta 2009, 1793:959-970.
21. Nikolaidis N., Chalkia D., Watkins D.N., Barrow R.K., Snyder S.H., van Rossum D.B., et al. Ancient origin of the new developmental superfamily DANGER. PLoS One 2007, 2:e204.
22. Zhang L., Lun Y., Yan D., Yu L., Ma W., Du B., et al. Proteomic analysis of macrophages: a new way to identify novel cell-surface antigens. J Immunol Methods 2007, 321:80-85.
23. Nogueira-Dantas E.O., Ferreira A.J., Astolfi-Ferreira C.S., Brentano L. Cloning and expression of chicken anemia virus VP3 protein in Escherichia coli. Comp Immunol Microbiol Infect Dis 2007, 30:133-142.
24. Ouyang P., Sugrue S.P. Characterization of pinin, a novel protein associated with the desmosome-intermediate filament complex. J Cell Biol 1996, 135:1027-1042.
25. Lamm D.L., Thor D.E., Harris S.C., Reyna J.A., Stogdill V.D., Radwin H.M. Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer. J Urol 1980, 124:38-40.
26. Melekos M.D., Moutzouris G.D. Intravesical therapy of superficial bladder cancer. Curr Pharm Des 2000, 6:345-359.
27. Jadus M.R., Irwin M.C., Irwin M.R., Horansky R.D., Sekhon S., Pepper K.A., et al. Macrophages can recognize and kill tumor cells bearing the membrane isoform of macrophage colony-stimulating factor. Blood 1996, 87:5232-5241.
28. Kato H., Horino A., Taneichi M., Fukuchi N., Eto Y., Ushijima H., et al. Macrophage inhibition of lymphocyte and tumor cell growth is mediated by 25-hydroxycholesterol in the cell membrane. Int Arch Allergy Immunol 1998, 117:78-84.
29. Takahashi S., Sakakibara Y., Mishiro E., Kouriki H., Nobe R., Kurogi K., et al. Molecular cloning, expression, and characterization of mouse amine N-sulfotransferases. Biochem Biophys Res Commun 2008, 375:531-535.
30. Song Y.M., Kim Y.S., Kim D., Lee D.S., Kwon H.J. Cloning, expression, and biochemical characterization of a new histone deacetylase-like protein from Thermus caldophilus GK24. Biochem Biophys Res Commun 2007, 361:55-61.
31. Vizoso Pinto M.G., Villegas J.M., Peter J., Haase R., Haas J., Lotz A.S., et al. LuMPIS-a modified luminescence-based mammalian interactome mapping pull-down assay for the investigation of protein-protein interactions encoded by GC-low ORFs. Proteomics 2009, 9:5303-5308.
32. Chow K.L., Hall D.H., Emmons S.W. The mab-21 gene of Caenorhabditis elegans encodes a novel protein required for choice of alternate cell fates. Development 1995, 121:3615-3626.
33. Wong Y.M., Chow K.L. Expression of zebrafish mab21 genes marks the differentiating eye, midbrain and neural tube. Mech Dev 2002, 113:149-152.
34. Mariani M., Baldessari D., Francisconi S., Viggiano L., Rocchi M., Zappavigna V., et al. Two murine and human homologs of mab-21, a cell fate determination gene involved in Caenorhabditis elegans neural development. Hum Mol Genet 1999, 8:2397-2406.
35. Yamada R., Mizutani-Koseki Y., Koseki H., Takahashi N. Requirement for Mab21l2 during development of murine retina and ventral body wall. Dev Biol 2004, 274:295-307.